The osteoarthritis therapeutics market is expected to reach a size of usd 26.31 billion by 2035. A subset of this market, knee osteoarthritis injectable treatments, is projected to reach usd 6.78 billion by the same year. The larger rheumatoid arthritis drugs market is expected to be significantly larger, potentially reaching usd 76.83 billion by 2035.